S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AMRX Amneal Pharmaceuticals Inc

8.20

-0.54 (-6.18%)

Pre Market

Last Updated: 06:00:03

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Amneal Pharmaceuticals (NASDAQ:AMRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Amneal Pharmaceuticals Charts.

Amneal Pharmaceuticals (NASDAQ:AMRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Amneal Pharmaceuticals Charts.

Amneal Pharmaceuticals Inc News

Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025
Wednesday 29 January 2025 (23 hours ago) • Business Wire

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 23 January 2025 (7 days ago) • Edgar (US Regulatory)

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Thursday 23 January 2025 (7 days ago) • Business Wire

Form 8-K - Current report
Wednesday 15 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 10 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 2 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Amneal to Participate at Upcoming Investor Conferences
Wednesday 4 December 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

More Amneal Pharmaceuticals Inc News Articles

3 1/2% Tr Gt 68

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions